The present invention is directed to compounds of formula (I):
described as novel indolizine derivatives and to a method for their preparation along with pharmaceutical compositions thereof whose substituents are as described in the specification.
本发明涉及式(I)的化合物:描述为新型
吲哚嗪衍
生物,并提供其制备方法以及其药物组成物,其取代基如规范中所述。